Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pyrazoloacridine in Metastatic Breast Cancer
NCT00002585Phase 2Completed
- Sponsor
- Barbara Ann Karmanos Cancer Institute
- Start
- Feb 1994
- Primary completion
- Oct 1999
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of pyrazoloacridine in breast cancer, sponsored by Barbara Ann Karmanos Cancer Institute. Started Feb 1994; status: completed.
02
Drugs
pyrazoloacridine
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT00002585.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00002585.